RxDoctor Payments Data

Carlos Chevere, MD

Radiation Oncology · Rio Piedras, PRNPI 1023025285

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,282 of the $7,750 with a category attached, or 81.1%. 17 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 48.7% of the total.

$7,750in general payments, 2019–2025

Across 117 payments — averaging $66.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$4K
  • Teleflex LLC$2K
  • Varian Medical Systems, Inc.$1K
  • Elekta, Inc.$316
  • AstraZeneca$261
  • Johnson & Johnson$129
  • plus $513 from 11 others

What the payments were for

  • Travel & lodging$1,38518%
  • Food & beverage$6,28281%
  • Entertainment$821%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few radiation oncology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$156,613
Medicare patients
18
Services billed
757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl19$147

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Rio Piedras

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →